Category Archives: Specialty HUBs

Trinity Life Sciences Adds Capabilities to Remain in the Forefront of Life Sciences Commercialization

The leading commercialization companies are rapidly adding product and service capabilities to offer a robust commercialization portfolio to life science companies

EVERSANA and Accord BioPharma Support Launch of CAMCEVI®

EVERSANA and Accord BioPharma announced a partnership to support the recent launch of CAMCEVI® (leuprolide) 42mg injection emulsion for the treatment of advanced prostate cancer in adults

AscellaHealth Offering Robust Commercialization and Market Access Services

AscellaHealth’s comprehensive portfolio of services results in streamlined access to therapy, optimal clinical results and an enhanced patient journey

Novo Holdings Acquires Life Science Commercialization Firm MKG

MedicalKnowedgeGroup (MKG) companies address the business needs of biopharmaceutical companies through the provision of network-mapping analytics, patient-finding analytics, and multi-channel marketing solutions

United BioSource Expands Capabilities for Biopharmaceutical Clients

This year, UBC has partnered with Seqster and acquired Marketshare Movers to advance the company’s capabilities in clinical trials and co-pay and affordability programs

Edenbridge Pharmaceuticals Selects Phil For Patient Access to DARTISLA ODT

Phil, Inc. is a software therapy deployment platform, offering pharmaceutical manufacturers a modern alternative to traditional access, affordability and distribution options